Abbott Laboratories (NYSE: ABT) stock was in fine health on the second-to-last trading day of the week, thanks to news from Europe. Investors greeted this positively, rewarding the company with a ...

Abbott Laboratories ... new products like the GridX mapping catheter, and strong momentum in structural heart devices, including MitraClip and TriClip. Overall, ABT ranks 8th on our list of ...

The decision to allow a new trial could have  implications for both the companies and families with babies born prematurely.